Next, four liver-specific TRAF3-transgenic (TRAF3-LTG) mouse lines were created to further validate the regulatory function of hepatocyte TRAF3 in hepatic steatosis-related obesity and insulin resistance (Supplementary Fig. 3a–c). Here, TRAF3 is linked to obesity disorder.